Clinical Trial Update: Induction Therapy With Anti-TNFα vs Cyclophosphamide in Severe Behçet Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing induction therapy with anti-TNFα versus cyclophosphamide in severe Behçet's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Behçet Disease
• Vasculitis

Drugs mentioned

• Anti-TNF-α (TNF-alpha inhibitor)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Behcet's Disease, Vasculitis | Phase 3 | Status: COMPLETED